Emerging disease information at your fingertips.
Provider
Resources
Providers &
Long Term Care
The resources you need, from treatment guidelines to the newest information on emerging conditions.
Recent Articles
→-
09/20/23 Health Advisory: New COVID-19 Vaccines Authorized, Previous Bivalent COVID-19 Vaccines Deauthorized
On Sept. 11, 2023, U.S. Food and Drug Administration (FDA) authorized for emergency use new, updated (2023–2024) COVID-19 vaccines from Moderna and Pfizer. FDA deauthorized previous bivalent COVID-19 vaccines. On Sept. 11, 2023, FDA deauthorized previous bivalent COVID-19 vaccines from Moderna and Pfizer. CDC recommends new, updated (2023–2024) COVID-19 vaccines. CDC’s new, updated (2023–2014) COVID-19…
-
04/24/23 Health Advisory: Bivalent COVID-19 Vaccine Use Expanded, Monovalent No Longer Authorized
Requested actions Monovalent Moderna and Pfizer COVID-19 vaccines are no longer authorized for use in the United States. Read below for how to discard and report as waste. Use the new simplified schedule to administer COVID-19 vaccine. People who are 65 years or older or have immune compromise can now get a second bivalent booster…
-
03/14/23 Health Advisory: Extensively Drug-Resistant Shigellosis
Requested actions Background Shigellosis is an acute enteric infection. It is an important cause of domestically acquired and travel-associated bacterial diarrhea in the United States. A low infectious dose makes Shigella bacteria easily transmitted from person to person. Consider shigellosis in the differential diagnosis of acute diarrhea, especially in people who: Shigellosis can be a mild,…